Carroll Financial Associates’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3K Hold
36
﹤0.01% 1428
2021
Q3
$4K Hold
36
﹤0.01% 1418
2021
Q2
$4K Hold
36
﹤0.01% 1477
2021
Q1
$5K Hold
36
﹤0.01% 1364
2020
Q4
$4K Hold
36
﹤0.01% 1291
2020
Q3
$4K Hold
36
﹤0.01% 1225
2020
Q2
$2K Hold
36
﹤0.01% 1350
2020
Q1
$2K Buy
+36
New +$2.76K ﹤0.01% 1293

Other funds holding GH

Carroll Financial Associates's GH Position: Q4 2021 in Review

Carroll Financial Associates held its Guardant Health (GH) position steady in Q4 2021 at 36 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Carroll Financial Associates first reported a position in GH in Q1 2020 and has held it in 8 quarters since. The position peaked at $5K in Q1 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Carroll Financial Associates held 36 shares of Guardant Health worth $3K as of Q4 2021.
  • Carroll Financial Associates left its Guardant Health share count unchanged in Q4 2021.
  • Guardant Health made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1428 holding.
  • Carroll Financial Associates first reported a position in Guardant Health in Q1 2020 and has held it in 8 quarters since.
  • Carroll Financial Associates's Guardant Health position peaked at $5K in Q1 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.